Coexistence of hereditary hemorrhagic telangeictasia and fibropolycystic liver disease

American Journal of Surgical Pathology

Volumn 22, Issue 3, 1998, Pages 368-372

  Saxena, Romil ^a,d   Hytiroglou, Prodromos ^a   Atillasoy, Evren O ^b   Cakaloglu, Yilmaz ^c   Emre, Sukru ^b   Thung, Swan N ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c Red Crescent Blood Center   (Turkey)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Fibropolycystic disease; Hereditary hemorrhagic telangiectasia; Liver transplantation; Osler Weber Rendu disease

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CASE REPORT; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER POLYCYSTIC DISEASE; LIVER TRANSPLANTATION; RELAPSING POLYCHONDRITIS; RENDU OSLER WEBER DISEASE;

ADULT; CYSTS; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER TRANSPLANTATION; POLYCYSTIC KIDNEY DISEASES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 0031934213     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199803000-00013     Document Type: Article

References (14)

1. Ball NJ, Duggan MA. Hepatolithiasis in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1990;114:423-5.
2. Daly JJ, Schiller AL. The liver in hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1976;60:723-6.
3. Fagel WJ, Perlberger R, Kauffmann RH. Portosystemic encephalopathy in hereditary hemorrhagic telangiectasia. Am J Med 1988;85:858-60.
4. Haitjema T, Westermann CJJ, Overtoom TTC. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). New insights in pathogenesis, complications, and treatment. Arch Intern Med 1996;156:714-9.
5. Harris PC, Ward CJ, Peral B, Hughes J. Polycystic kidney disease I: Identification and analysis of the primary defect. J Am Soc Nephrol 1995;6:1125-33.
6. McAllister KA, Grogg KM, Johnson DW, et al. Endoglobin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nature Genet 1994;8:345-51.
7. Mendoza A, Oligff S, Elias E. Hereditary hemorrhagic telangiectasia and secondary biliary cirrhosis. Eur J Gastroenterol Hepatol 1995;7:999-1002.
8. Ozgen F. Hereditary hemorrhagic telangiectasia presenting with portal hypertension and cirrhosis of the liver. A case report. Gastroenterolagy 1984;79:363-7.
9. Peery WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1987;82:989-97.
10. Reilly PJ, Nostrant MD. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1984;79:363-7.
11. Solomon S, Kleiman AH. Hereditary hemorrhagic telangiectasia with polycystic disease of kidneys. N Y State J Med 1971;71:1665-8.
12. Van Adelsberg JS, Frank D. The PKD1 gene produces a developmentally regulated protein in mesenchyme and vasculature. Nature Med 1995;1:359-64.
13. Vincent P, Plauchu H, Hazan J, et al. A third locus for hereditary hemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet 1995;4:945-9.
14. Wanless IR, Gryfe A. Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 1986;110:331-5.